U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
152281152281Gene Regulation by ThiazolidinedionesCompletedHas ResultsInflammatory Bowel DiseaseDrug: Rosiglitazonehttps://ClinicalTrials.gov/show/NCT00567593
152282152282Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising Prostate Specific Antigen (PSA) After Surgery for Prostate CancerActive, not recruitingNo Results AvailableProstate CancerDrug: bicalutamide|Drug: flutamide|Radiation: radiation therapyhttps://ClinicalTrials.gov/show/NCT00567580
152283152283Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk NeuroblastomaActive, not recruitingNo Results AvailableLocalized Resectable Neuroblastoma|Localized Unresectable Neuroblastoma|Recurrent Neuroblastoma|Regional Neuroblastoma|Stage 4 Neuroblastoma|Stage 4S NeuroblastomaProcedure: Autologous Hematopoietic Stem Cell Transplantation|Drug: Carboplatin|Drug: Cisplatin|Drug: Cyclophosphamide|Drug: Doxorubicin Hydrochloride|Drug: Etoposide|Radiation: External Beam Radiation Therapy|Biological: Filgrastim|Drug: Isotretinoin|Other: Laboratory Biomarker Analysis|Drug: Melphalan|Procedure: Peripheral Blood Stem Cell Transplantation|Other: Pharmacological Study|Drug: Thiotepa|Drug: Topotecan Hydrochloride|Drug: Vincristine Sulfate Liposomehttps://ClinicalTrials.gov/show/NCT00567567
152284152284A Phase III Trials Program Exploring the Integration of Bevacizumab, Everolimus (RAD001), and Lapatinib Into Current Neoadjuvant Chemotherapy Regimes for Primary Breast CancerActive, not recruitingNo Results AvailableBreast CancerDrug: epirubicin - cyclophosphamide / docetaxel|Drug: epirubicin - cyclophosphamide / docetaxel + bevacizumab|Drug: paclitaxel|Drug: paclitaxel + everolimus (RAD001)|Drug: epirubicin - cyclophosphamide / docetaxel + trastuzumab|Drug: epirubicin - cyclophosphamide / docetaxel + lapatinibhttps://ClinicalTrials.gov/show/NCT00567554
152285152285An Implantable Microstimulator for the Treatment of Chronic Shoulder Pain in Chronic Post-Stroke SubjectsCompletedNo Results AvailableShoulder Pain ChronicDevice: Battery Powered Microstimulator (BBPM)https://ClinicalTrials.gov/show/NCT00567541
152286152286Comparison of the Efficacy of Topical Ibuprofen to Oral Ibuprofen in Adolescent AthletesTerminatedNo Results AvailableSoft Tissue InjuryDrug: Ibuprofen|Drug: ibuprofenhttps://ClinicalTrials.gov/show/NCT00567528
152287152287Safety and Effectiveness of Left Atrial Appendage OcclusionCompletedNo Results AvailableAtrial FibrillationDevice: AtriCure LAA Exclusion Systemhttps://ClinicalTrials.gov/show/NCT00567515
152288152288Safety and Pregnancy Outcomes in Thrombocythemia Patients Exposed to Xagrid Compared to Other TreatmentsCompletedNo Results AvailableThrombocythemia, Essentialhttps://ClinicalTrials.gov/show/NCT00567502
152289152289IMPENDIA- PEN VS Dianeal Only Improved Metabolic Control In Diabetic CAPD and APD PatientsCompletedNo Results AvailableESRD|Diabetes|CAPD|APDDrug: Physioneal|Drug: Dianeal|Drug: Extraneal|Drug: Nutrinealhttps://ClinicalTrials.gov/show/NCT00567489
152290152290Omalizumab Use and Asthma-Related Quality of Life in Patients With Severe Persistent Allergic AsthmaCompletedHas ResultsAsthmaDrug: Omalizumab|Drug: Inhaled corticosteroids (ICS)|Drug: Long-acting beta 2-adrenergic agonist (LABA)|Drug: Short-acting beta 2-adrenergic agonist (SABA)https://ClinicalTrials.gov/show/NCT00567476
152291152291Early Antiinflammatory Treatment of AsthmaTerminatedNo Results AvailableAsthma|Bronchial HyperreactivityDevice: Fluticasonehttps://ClinicalTrials.gov/show/NCT00567463
152292152292Ropivacaine Versus Ropivacaine Plus Mepivacaine for Sciatic BlockCompletedNo Results AvailableSubgluteal Sciatic BlockDrug: ropivacaine|Drug: ropivacaine plus mepivacainehttps://ClinicalTrials.gov/show/NCT00567450
152293152293Utility of Exercise-induced N-terminal (NT) Pro-brain Natriuretic Peptide Levels in Predicting Prognosis in Asymptomatic Aortic StenosisTerminatedNo Results AvailableAortic StenosisOther: NT-pro-BNP levelshttps://ClinicalTrials.gov/show/NCT00567437
152294152294GW273225 Therapy Added To Current Seizure Treatments In Patients With Partial SeizuresWithdrawnNo Results AvailableEpilepsyDrug: GW273225https://ClinicalTrials.gov/show/NCT00567424
152295152295Comparison of the Alpha-2 Agonists for Prevention of Intraocular Pressure Elevation After Selective Laser TrabeculoplastyRecruitingNo Results AvailableGlaucoma|Ocular HypertensionDrug: brimonidine 0.1%|Drug: Apraclonidine 0.5%https://ClinicalTrials.gov/show/NCT00567411
152296152296IMPENDIA- PEN VS Dianeal Only Improved Metabolic Control In Diabetic CAPD and APD PatientsCompletedNo Results AvailableESRD|DiabetesDrug: Dianeal|Drug: Physioneal|Drug: Extraneal|Drug: Nutrinealhttps://ClinicalTrials.gov/show/NCT00567398
152297152297Liquid Somatropin Formulation in Children With Growth Hormone DeficiencyCompletedNo Results AvailableGrowth Hormone Disorder|Growth Hormone Deficiency in ChildrenDrug: somatropinhttps://ClinicalTrials.gov/show/NCT00567385
152298152298POSTERIOR SUB-TENON'S AvastinRecruitingNo Results AvailableDiffuse Diabetic Macular EdemaDrug: bevacizumab (Sub-tenon´s injection)https://ClinicalTrials.gov/show/NCT00567372
152299152299Erlotinib in Patients With Resected, Early Stage NSCLC With Confirmed Mutations in the EGFRActive, not recruitingNo Results AvailableNon-small Cell Lung CancerDrug: Erlotinibhttps://ClinicalTrials.gov/show/NCT00567359
152300152300Efficacy and Safety of Grass Pollen Sublingual ImmunotherapyCompletedNo Results AvailableAllergic RhinoconjunctivitisDrug: Oralgen|Drug: grass pollen extracthttps://ClinicalTrials.gov/show/NCT00567346
152301152301Individualized Chiropractic and Integrative Care for Low Back PainCompletedNo Results AvailableSub-Acute and Chronic Low Back PainOther: Chiropractic care|Other: Multidisciplinary, integrative carehttps://ClinicalTrials.gov/show/NCT00567333
152302152302Efficacy of Varenicline in Methadone-Stabilized Cocaine UsersCompletedHas ResultsCocaine Dependence|Nicotine DependenceDrug: Varenicline|Drug: Sugar pill or Placebohttps://ClinicalTrials.gov/show/NCT00567320
152303152303Polypill For Prevention of Cardiovascular DiseaseCompletedNo Results AvailableCardiovascular DiseaseDrug: Red Heart Pill 2b (Polypill)|Other: Standard Practicehttps://ClinicalTrials.gov/show/NCT00567307
152304152304Evaluating Ways to Improve Medication Use Among People With OsteoporosisCompletedNo Results AvailableOsteoporosisBehavioral: Mailed education|Behavioral: Telephone coaching program for patients|Behavioral: Medication adherence alert program for doctorshttps://ClinicalTrials.gov/show/NCT00567294
152305152305Bilateral Repetitive Transcranial Magnetic Stimulation for Auditory HallucinationsActive, not recruitingNo Results AvailableSchizophreniaDevice: Magstim Rapid 2 system triggering Magstim Super Rapid system|Device: Magstim Rapid-2 system triggering Magstim Super Rapid systemhttps://ClinicalTrials.gov/show/NCT00567281
152306152306Drug Use Investigation Of GabapentinCompletedHas ResultsEpilepsies, PartialDrug: Gabapentinhttps://ClinicalTrials.gov/show/NCT00567268
152307152307A Safety and Efficacy Study of Naltrexone SR/Bupropion SR in Overweight and Obese SubjectsCompletedHas ResultsObesity|OverweightDrug: Naltrexone SR 32 mg/bupropion SR 360 mg/day|Drug: Placebo|Behavioral: Ancillary therapyhttps://ClinicalTrials.gov/show/NCT00567255
152308152308Treating Intention In Aphasia: Neuroplastic SubstratesCompletedHas ResultsAphasia|Cerebrovascular AccidentBehavioral: Word-finding with intention component|Behavioral: Word-finding with no intention componenthttps://ClinicalTrials.gov/show/NCT00567242
152309152309Lenalidomide and Rituximab in Treating Patients With Recurrent and/or Refractory Multiple MyelomaTerminatedNo Results AvailableMultiple Myeloma and Plasma Cell NeoplasmBiological: rituximab|Drug: lenalidomide|Genetic: microarray analysis|Other: flow cytometry|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00567229
152310152310Endoscopic Cyanoacrylate Obliteration vs. Nadolol Treatment in the Prevention of Gastric Variceal RebleedingRecruitingNo Results AvailableLiver Cirrhosis and Hepatoma.|Gastric Variceal BleedingDrug: Nadololhttps://ClinicalTrials.gov/show/NCT00567216

* Görseller ve İçerik tekif hakkına sahip olabilir